Skip to main content

Table 2 Genotype frequencies of the two tumour necrosis factor (TNF) polymorphisms in breast cancer patients and controls

From: Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity

Genotype TNF-α-308G>A polymorphism TNF-α-238G>A polymorphism
  Breast cancer (n = 705) Screening controls (n = 498) Breast cancer (n = 708) Screening controls (n = 495)
GG 475 (67.4%) 313 (62.9%) 621 (87.7%) 434 (87.7%)
GA 208 (29.5%) 167 (33.5%) 84 (11.9%) 59 (11.9%)
AA 22 (3.1%) 18 (3.6%) 3 (0.4%) 2 (0.4%)
\